Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation
The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2002-04, Vol.277 (16), p.13682-13692 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 13692 |
---|---|
container_issue | 16 |
container_start_page | 13682 |
container_title | The Journal of biological chemistry |
container_volume | 277 |
creator | Voisin, Mathieu-Benoı̂t Bitard, Juliette Daburon, Sophie Moreau, Jean-François Taupin, Jean-Luc |
description | The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor. |
doi_str_mv | 10.1074/jbc.M111624200 |
format | Article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04669425v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925819609634</els_id><sourcerecordid>18310635</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-b06c5fccc25c108bf9896166dc259a6eeb118548303afe9c4dd852f5b64c7f0f3</originalsourceid><addsrcrecordid>eNp1kV9v0zAUxSMEYmXwyiPyA0JCWoqdP07yWArdJqVCgiHxZjnOdestsTs7ael35ENxu5btCb_Yvv6d66tzougto1NGi-zTbaOmS8YYT7KE0mfRhNEyjdOc_XoeTShNWFwleXkWvQrhluLKKvYyOmOsTLMirSbRnx-wkV4OQBajVYNxNhDtPBnWQG52jixdO3YQiNMPpSX0jZcW4o13v00vOzLfD-7OWCCfjW2NXZEvrpfGHgSX3V45BAfAO6voxUOLGsY76I0k13ZtGjM4vycLqXAntduRmdbGmmFPvoOCDVYvCKprs5K2ffzjcP73TmY49lYeRn8dvdCyC_DmtJ9HPxdfb-ZXcf3t8no-q2OVFdkQN5SrXCulklyhXY2uyoozzlssVJIDNOhPnpUpTaWGSmVtW-aJzhueqUJTnZ5HH49917ITG48--L1w0oirWS0ONZpxXmVJvmXIfjiyaMT9CGEQvQkKug5ddGMQmASjPM0RnB5B5V0IHvRjZ0bFIWuBWYunrFHw7tR5bHpon_BTuAi8P41pVuud8SAa49QaepEUhWBcsJSXCWLlEQO0bGvAi6AMWAUtStQgWmf-N8JfVJHF5w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18310635</pqid></control><display><type>article</type><title>Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Voisin, Mathieu-Benoı̂t ; Bitard, Juliette ; Daburon, Sophie ; Moreau, Jean-François ; Taupin, Jean-Luc</creator><creatorcontrib>Voisin, Mathieu-Benoı̂t ; Bitard, Juliette ; Daburon, Sophie ; Moreau, Jean-François ; Taupin, Jean-Luc</creatorcontrib><description>The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M111624200</identifier><identifier>PMID: 11834739</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Amino Acid Sequence ; Animals ; Antibodies, Monoclonal ; Antibodies, Monoclonal - metabolism ; Antigens, Neoplasm ; Antigens, Neoplasm - chemistry ; Antigens, Neoplasm - metabolism ; Cell Division ; Cell Line ; Cell Membrane ; Cell Membrane - metabolism ; CHO Cells ; COS Cells ; Cricetinae ; Cytokines ; Cytokines - metabolism ; Dimerization ; DNA-Binding Proteins ; DNA-Binding Proteins - metabolism ; Dose-Response Relationship, Drug ; Enzyme-Linked Immunosorbent Assay ; Fibronectins ; Fibronectins - metabolism ; Flow Cytometry ; Gene Deletion ; glycoprotein gp190 ; Growth Inhibitors ; Growth Inhibitors - pharmacology ; Humans ; Interleukin-6 ; Leukemia Inhibitory Factor ; Leukemia Inhibitory Factor Receptor alpha Subunit ; LIF protein ; Life Sciences ; Ligands ; Lymphokines ; Lymphokines - pharmacology ; Mice ; Molecular Sequence Data ; Mutation ; Phosphorylation ; Protein Binding ; Protein Conformation ; Protein Structure, Tertiary ; Receptors, Cytokine ; Receptors, Cytokine - chemistry ; Receptors, Cytokine - metabolism ; Receptors, OSM-LIF ; STAT3 Transcription Factor ; Trans-Activators ; Trans-Activators - metabolism ; Transfection</subject><ispartof>The Journal of biological chemistry, 2002-04, Vol.277 (16), p.13682-13692</ispartof><rights>2002 © 2002 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-b06c5fccc25c108bf9896166dc259a6eeb118548303afe9c4dd852f5b64c7f0f3</citedby><cites>FETCH-LOGICAL-c474t-b06c5fccc25c108bf9896166dc259a6eeb118548303afe9c4dd852f5b64c7f0f3</cites><orcidid>0000-0001-6626-3522</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11834739$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04669425$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Voisin, Mathieu-Benoı̂t</creatorcontrib><creatorcontrib>Bitard, Juliette</creatorcontrib><creatorcontrib>Daburon, Sophie</creatorcontrib><creatorcontrib>Moreau, Jean-François</creatorcontrib><creatorcontrib>Taupin, Jean-Luc</creatorcontrib><title>Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antibodies, Monoclonal</subject><subject>Antibodies, Monoclonal - metabolism</subject><subject>Antigens, Neoplasm</subject><subject>Antigens, Neoplasm - chemistry</subject><subject>Antigens, Neoplasm - metabolism</subject><subject>Cell Division</subject><subject>Cell Line</subject><subject>Cell Membrane</subject><subject>Cell Membrane - metabolism</subject><subject>CHO Cells</subject><subject>COS Cells</subject><subject>Cricetinae</subject><subject>Cytokines</subject><subject>Cytokines - metabolism</subject><subject>Dimerization</subject><subject>DNA-Binding Proteins</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Fibronectins</subject><subject>Fibronectins - metabolism</subject><subject>Flow Cytometry</subject><subject>Gene Deletion</subject><subject>glycoprotein gp190</subject><subject>Growth Inhibitors</subject><subject>Growth Inhibitors - pharmacology</subject><subject>Humans</subject><subject>Interleukin-6</subject><subject>Leukemia Inhibitory Factor</subject><subject>Leukemia Inhibitory Factor Receptor alpha Subunit</subject><subject>LIF protein</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Lymphokines</subject><subject>Lymphokines - pharmacology</subject><subject>Mice</subject><subject>Molecular Sequence Data</subject><subject>Mutation</subject><subject>Phosphorylation</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Protein Structure, Tertiary</subject><subject>Receptors, Cytokine</subject><subject>Receptors, Cytokine - chemistry</subject><subject>Receptors, Cytokine - metabolism</subject><subject>Receptors, OSM-LIF</subject><subject>STAT3 Transcription Factor</subject><subject>Trans-Activators</subject><subject>Trans-Activators - metabolism</subject><subject>Transfection</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV9v0zAUxSMEYmXwyiPyA0JCWoqdP07yWArdJqVCgiHxZjnOdestsTs7ael35ENxu5btCb_Yvv6d66tzougto1NGi-zTbaOmS8YYT7KE0mfRhNEyjdOc_XoeTShNWFwleXkWvQrhluLKKvYyOmOsTLMirSbRnx-wkV4OQBajVYNxNhDtPBnWQG52jixdO3YQiNMPpSX0jZcW4o13v00vOzLfD-7OWCCfjW2NXZEvrpfGHgSX3V45BAfAO6voxUOLGsY76I0k13ZtGjM4vycLqXAntduRmdbGmmFPvoOCDVYvCKprs5K2ffzjcP73TmY49lYeRn8dvdCyC_DmtJ9HPxdfb-ZXcf3t8no-q2OVFdkQN5SrXCulklyhXY2uyoozzlssVJIDNOhPnpUpTaWGSmVtW-aJzhueqUJTnZ5HH49917ITG48--L1w0oirWS0ONZpxXmVJvmXIfjiyaMT9CGEQvQkKug5ddGMQmASjPM0RnB5B5V0IHvRjZ0bFIWuBWYunrFHw7tR5bHpon_BTuAi8P41pVuud8SAa49QaepEUhWBcsJSXCWLlEQO0bGvAi6AMWAUtStQgWmf-N8JfVJHF5w</recordid><startdate>20020419</startdate><enddate>20020419</enddate><creator>Voisin, Mathieu-Benoı̂t</creator><creator>Bitard, Juliette</creator><creator>Daburon, Sophie</creator><creator>Moreau, Jean-François</creator><creator>Taupin, Jean-Luc</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-6626-3522</orcidid></search><sort><creationdate>20020419</creationdate><title>Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation</title><author>Voisin, Mathieu-Benoı̂t ; Bitard, Juliette ; Daburon, Sophie ; Moreau, Jean-François ; Taupin, Jean-Luc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-b06c5fccc25c108bf9896166dc259a6eeb118548303afe9c4dd852f5b64c7f0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antibodies, Monoclonal</topic><topic>Antibodies, Monoclonal - metabolism</topic><topic>Antigens, Neoplasm</topic><topic>Antigens, Neoplasm - chemistry</topic><topic>Antigens, Neoplasm - metabolism</topic><topic>Cell Division</topic><topic>Cell Line</topic><topic>Cell Membrane</topic><topic>Cell Membrane - metabolism</topic><topic>CHO Cells</topic><topic>COS Cells</topic><topic>Cricetinae</topic><topic>Cytokines</topic><topic>Cytokines - metabolism</topic><topic>Dimerization</topic><topic>DNA-Binding Proteins</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Fibronectins</topic><topic>Fibronectins - metabolism</topic><topic>Flow Cytometry</topic><topic>Gene Deletion</topic><topic>glycoprotein gp190</topic><topic>Growth Inhibitors</topic><topic>Growth Inhibitors - pharmacology</topic><topic>Humans</topic><topic>Interleukin-6</topic><topic>Leukemia Inhibitory Factor</topic><topic>Leukemia Inhibitory Factor Receptor alpha Subunit</topic><topic>LIF protein</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Lymphokines</topic><topic>Lymphokines - pharmacology</topic><topic>Mice</topic><topic>Molecular Sequence Data</topic><topic>Mutation</topic><topic>Phosphorylation</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Protein Structure, Tertiary</topic><topic>Receptors, Cytokine</topic><topic>Receptors, Cytokine - chemistry</topic><topic>Receptors, Cytokine - metabolism</topic><topic>Receptors, OSM-LIF</topic><topic>STAT3 Transcription Factor</topic><topic>Trans-Activators</topic><topic>Trans-Activators - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Voisin, Mathieu-Benoı̂t</creatorcontrib><creatorcontrib>Bitard, Juliette</creatorcontrib><creatorcontrib>Daburon, Sophie</creatorcontrib><creatorcontrib>Moreau, Jean-François</creatorcontrib><creatorcontrib>Taupin, Jean-Luc</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Voisin, Mathieu-Benoı̂t</au><au>Bitard, Juliette</au><au>Daburon, Sophie</au><au>Moreau, Jean-François</au><au>Taupin, Jean-Luc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2002-04-19</date><risdate>2002</risdate><volume>277</volume><issue>16</issue><spage>13682</spage><epage>13692</epage><pages>13682-13692</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11834739</pmid><doi>10.1074/jbc.M111624200</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6626-3522</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2002-04, Vol.277 (16), p.13682-13692 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_04669425v1 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Amino Acid Sequence Animals Antibodies, Monoclonal Antibodies, Monoclonal - metabolism Antigens, Neoplasm Antigens, Neoplasm - chemistry Antigens, Neoplasm - metabolism Cell Division Cell Line Cell Membrane Cell Membrane - metabolism CHO Cells COS Cells Cricetinae Cytokines Cytokines - metabolism Dimerization DNA-Binding Proteins DNA-Binding Proteins - metabolism Dose-Response Relationship, Drug Enzyme-Linked Immunosorbent Assay Fibronectins Fibronectins - metabolism Flow Cytometry Gene Deletion glycoprotein gp190 Growth Inhibitors Growth Inhibitors - pharmacology Humans Interleukin-6 Leukemia Inhibitory Factor Leukemia Inhibitory Factor Receptor alpha Subunit LIF protein Life Sciences Ligands Lymphokines Lymphokines - pharmacology Mice Molecular Sequence Data Mutation Phosphorylation Protein Binding Protein Conformation Protein Structure, Tertiary Receptors, Cytokine Receptors, Cytokine - chemistry Receptors, Cytokine - metabolism Receptors, OSM-LIF STAT3 Transcription Factor Trans-Activators Trans-Activators - metabolism Transfection |
title | Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T00%3A44%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Separate%20Functions%20for%20the%20Two%20Modules%20of%20the%20Membrane-proximal%20Cytokine%20Binding%20Domain%20of%20Glycoprotein%20190,%20the%20Leukemia%20Inhibitory%20Factor%20Low%20Affinity%20Receptor,%20in%20Ligand%20Binding%20and%20Receptor%20Activation&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Voisin,%20Mathieu-Beno%C4%B1%CC%82t&rft.date=2002-04-19&rft.volume=277&rft.issue=16&rft.spage=13682&rft.epage=13692&rft.pages=13682-13692&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M111624200&rft_dat=%3Cproquest_hal_p%3E18310635%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18310635&rft_id=info:pmid/11834739&rft_els_id=S0021925819609634&rfr_iscdi=true |